Human estrogen receptor α (ER) and epidermal growth factor receptor 2 (HER2) are closely related to the development of the incidence levels of breast cancer, which determine the molecular markers of breast cancer subtypes and the treatment of breast cancer programs. This evidence concerns the gene ESR1 and breast cancer.